(ITOS) Iteos Therapeutics - Performance -45.1% in 12m
Compare ITOS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-82.91%
#132 in Group
Rel. Strength
18.90%
#6453 in Universe
Total Return 12m
-45.08%
#81 in Group
Total Return 5y
-64.83%
#69 in Group
P/E -
(?) Percentile in Group
P/E Forward 12.6
44th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -41.53%
(?) Percentile in Group
12m Total Return: ITOS (-45.1%) vs XBI (-12.3%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: ITOS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ITOS
| Total Return (including Dividends) | ITOS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 32.94% | 11.81% | 13.81% |
| 3 Months | -6.69% | -13.61% | -6.30% |
| 12 Months | -45.08% | -12.29% | 10.65% |
| 5 Years | -64.83% | -24.89% | 107.77% |
| Trend Score (consistency of price movement) | ITOS | XBI | S&P 500 |
| 1 Month | 61.1% | 72.9% | 83% |
| 3 Months | -38.1% | -83% | -75.3% |
| 12 Months | -94.0% | -51.6% | 50.1% |
| 5 Years | -86.7% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #13 | 18.9% | 16.8% |
| 3 Month | #39 | 8.02% | -0.41% |
| 12 Month | #82 | -37.4% | -50.4% |
| 5 Years | #63 | -49.6% | -81.4% |
FAQs
Does ITOS Iteos Therapeutics outperforms the market?
No,
over the last 12 months ITOS made -45.08%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months ITOS made -6.69%, while XBI made -13.61%.
Over the last 3 months ITOS made -6.69%, while XBI made -13.61%.
Performance Comparison ITOS vs Indeces and Sectors
ITOS vs. Indices ITOS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -11.9% | 19.1% | -22.8% | -55.7% |
| US NASDAQ 100 | QQQ | -12.0% | 15.6% | -23.0% | -56.7% |
| US Dow Jones Industrial 30 | DIA | -12.3% | 23.0% | -22.5% | -52.8% |
| German DAX 40 | DAX | -11.8% | 18.0% | -49.1% | -70.8% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -14.0% | 21.1% | -23.6% | -52.5% |
| Hongkong Hang Seng | HSI | -15.0% | 13.0% | -31.1% | -58.8% |
| India NIFTY 50 | INDA | -6.93% | 28.1% | -23.2% | -44.9% |
| Brasil Bovespa | EWZ | -12.9% | 15.7% | -31.5% | -36.8% |
ITOS vs. Sectors ITOS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -12.5% | 19.5% | -29.8% | -66.6% |
| Consumer Discretionary | XLY | -12.2% | 18.7% | -21.8% | -59.4% |
| Consumer Staples | XLP | -11.0% | 26.4% | -29.7% | -54.2% |
| Energy | XLE | -11.7% | 26.2% | -16.2% | -35.6% |
| Financial | XLF | -13.0% | 19.4% | -29.9% | -67.5% |
| Health Care | XLV | -8.84% | 32.1% | -17.8% | -41.0% |
| Industrial | XLI | -13.5% | 16.1% | -24.2% | -56.1% |
| Materials | XLB | -11.7% | 19.4% | -17.9% | -39.9% |
| Real Estate | XLRE | -10.5% | 21.4% | -23.5% | -60.5% |
| Technology | XLK | -12.9% | 11.7% | -19.9% | -52.2% |
| Utilities | XLU | -11.9% | 23.4% | -30.4% | -62.6% |
| Aerospace & Defense | XAR | -13.8% | 11.8% | -34.3% | -72.4% |
| Biotech | XBI | -5.26% | 21.1% | -2.64% | -32.8% |
| Homebuilder | XHB | -12.3% | 21.5% | -9.59% | -37.5% |
| Retail | XRT | -13.8% | 18.3% | -18.5% | -43.6% |